Sanofi Lacks System To Prevent Microbial Contamination At Its German Plant, FDA Says
Executive Summary
Sanofi-Aventis has not established or followed appropriate written procedures to prevent microbiological contamination of drug products at its manufacturing facility in Frankfurt, FDA told the company.